Clinical Trials Unit
The Emory-CDC HIV/AIDS Clinical Trials Unit:
- 5 sites
- 3 continents
- 2 institutions
- 1 mission
Click About Us to learn more
Hot off the press
A5332: REPRIEVE Primary Results Now Available in NEJM!
We are pleased to share that the primary results of the REPRIEVE Trial have been published in the New England Journal of Medicine and are now available online!
A PDF version of the publication, supplement, and Plain Language Summary* are linked below. Press releases about the trial results have been issued from The National Institutes of Health, Massachusetts General Hospital, and the AIDS Clinical Trials Group. and can be accessed via the links below.
We are pleased to share this information with our participants and community members to ensure that you are aware of the REPRIEVE results. For more news updates, please refer to the REPRIEVE website: https://www.reprievetrial.org/learnmore/news/.
To read other papers we have published, like those published before 2013, click Publications
Clinical Research Sites
The leardership and supervision of the five sites that make up the clinical trials unit (CTU) is divided among its two institutions (Emory University and the Centers for Disease Control and Prevention [CDC]). Emory overseas the two USA-based sites and the protocol specific site in the Philippines, while CDC overseas the two additional international sites.
Please visit the pages below to learn about these five sites
Picture taken at 2016 Annual Community Advisory Board (CAB) retreat. From Left to Right: Drs. Lennox, del Rio, and Edupuganti and two of our CAB members, Neena Smith-Bankhead and Reggie Dunbar.
To get up-to-date information about global/national HIV/AIDS prevention, treatment, and research efforts, click here